This announcement is a separate document:
昭栄薬品：2025年３月期第２四半期（中間期）連結業績予想と実績との差異及び通期連結業績予想の修正に関するお知らせ
Shoei Yakuhin: Notice regarding differences between consolidated earnings forecasts and actual results for the second quarter (interim period) of the fiscal year ending March 31, 2025 and revisions to the full-year consolidated earnings forecast
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated